Cite
HARVARD Citation
Vijayan, S. et al. (2022). Real‐world evidence for subcutaneous infliximab (CT‐P13 SC) treatment in patients with ankylosing spondylitis during the coronavirus disease (COVID‐19) pandemic: A case series. Clinical case reports. 10 (1), p. n/a. [Online].